4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-24-050141
Pres&Chief Investment Officer sold 412,584 shares at $12.05 ($4,971,637)
- Pres&Chief Investment Officer acquired 412,584 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-18 | Option exercise | +412,584 | $3.85 | $1,588,448 | 19,249,131 | D |
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-18 | Sale | −412,584 | $12.05 | $4,971,637 | 18,836,547 | D |
| Derivatives | |||||||
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-18 | Option exercise · Stock Option (Right to Buy) | −412,584 | 16,110,600 | D | ||
| Open-market sales · 412,584 sh · avg $12.05 · $4,971,637 | |||||||
Loading xslF345X05/form4.xml…